1. Reaven et al. Syndrome X: The Silent Killer; The New Heart Disease Risk. Simon & Schuster, 2001.
2. Cromwell WC et al. LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study – Implications for LDL Management. J Clin Lipidol. 2007 Dec;1(6):583-92. doi: 10.1016/j.jacl.2007.10.001.
3. Stanimirovic J et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular disease. Crit Rev Clin Lab Sci 2015; 52: 70-85
4. Gonçalves I et al. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1505-12. doi: 10.1161/ATVBAHA.112.249854. Epub 2012 Apr 12.